The relative proportions of the four coproporphyrin isomers I-IV were analysed in faeces of 20 healthy subjects and 60 patients suffering from one of the seven common types of hepatic or erythropoietic hereditary porphyrias. A newly developed, reliable method for sample preparation was applied, using reversed-phase thinlayer chromatography for the isolation of naturally occurring coproporphyrin free carboxylic acids. Accurate separation and quantitation of the individual isomers I-IV were achieved with the help of ion-pair high-performance liquid chromatography. The four coproporphyrin isomers I-IV were positively identified by on-line scanning of their fluorescence spectra in the emission and excitation modes. Recovery rates with this new analytical procedure were between 90 and 100%, and coefficients of variation varied between 0.8 and 5.7% (N = 7).
Introduction
The porphyrias arise from inherited or acquired disor-Routes of elimination of different porphyrins mainly ders of enzymes in the haem biosynthetic pathway, re-depend on the polarity of their molecular structure, suiting in excessive production of porphyrins or porphy-The highly polar uroporphyrin, carrying eight carboxyl rin precursors (1).
groups, is predominantly found in urine, whereas the apolar protoporphyrin is excreted exclusively via bilẽ ,_ UT , , " . r, . and faeces. The medium polarity of coproporphyrin
The diagnosis of porphyrias is-based on the analysis of porphyrins and porphyrin precursors in clinical materials, e.g., urine, faeces and blood (1, 2). Measurement of faecal porphyrins is particularly helpful for diagnosing the different acute hepatic porphyrias: acute intermittent porphyria, variegate porphyria, hereditary coproporphyria and porphobilinogen synthase deficiency porphyria. Increased faecal porphyrin excretion is also observed in chronic porphyrias, such as congenital erythropoietic porphyria, porphyria cutanea tarda and protoporphyria. The determination of porphyrin isomer ratios provides additional information for the differential diagnosis of porphyrias, especially when the ratio of coproporphyrin isomers I and III is altered (3, 4) . Finally, the analysis of haem biosynthetic enzyme activities allows the identification of the causative enzyme deficiency in patients and often also in asymptomatic family members carrying the defective gene (1).
In a recent study, we analysed the relative proportions of the four ppproporphyrin isomers I-IV in urine of patients suffering from the common types of hereditary porphyria (4) . We observed significantly increased proportions of coproporphyrin III in acute hepatic porphyrias as compared with chronic hepatic porphyrias. In contrast, the highest proportion of coproporphyrin I was found in congenital erythropoietic porphyria which results from a defect of uroporphyrinogen III cosynthase 2 ). The atypical coproporphyrin isomers II and IV were present in all types of porphyria investigated, but did not provide additional diagnostic information. Here, we report results of a subsequent study of the excretion of the four coproporphyrin isomers I-IV in faeces from patients with the common types of hereditary porphyrias. Application of a newly developed reversed-phase thin-layer Chromatographie (TLC) method allowed a highly selective isolation of free faecal coproporphyrins I-IV, which were completely separated and quantitated by isocratic ion-pair high-performance liquid chromatography (HPLC) (5) . Another aim of this study was to compare the results of faecal and urinary coproporphyrin isomer ratios in the corresponding types of porphyria, and to evaluate the diagnostic relevance of faecal coproporphyrin isomers I-IV.
Materials and Methods

Patients
Stool samples were analysed from 20 healthy subjects (12 following types of porphyria: congenital erythropoietic porphyria (N = 6), erythrohepatic protoporphyria (N = 7), porphyria cutanea tarda (N = 13), acute intermittent porphyria (N = 15), porphobilinogen synthase deficiency porphyria (N = 2), variegate porphyria (N = 7), hereditary coproporphyria (N = 10). Diagnosis of the respective porphyrias was based on biochemical measurements and characteristic clinical symptoms in manifest cases.
. r Table 1 shows the clinical status and faecal porphyrin excretion of seven selected patients with different types of hereditary porphyria.
Stool samples
Stool samples were protected from light, freeze-dried and kept frozen at -20 °C until analysis.
Analysis of faecal protoporphyrin and total coproporphyrins
Total coproporphyrins and protoporphyrin in faeces were determined by the high-performance thin-layer Chromatographie method of Doss (1).
Sample preparation for determination of coproporphyrins I -IV Faeces (10 to 100 mg, depending on the respective content of total coproporphyrins) were suspended in 2 ml 9 g/1 aqueous NaCl, oxi- as compared with the previously used methyl ester method (16) .
HPLC analysis
The four coproporphyrin isomers I-IV were completely separated by isocratic ion-pair HPLC as described previously (5). This highly selective isolation procedure provides clean chromatograms for faecal coproporphyrins, which were not affected by interfering substances ( fig. la, b) . Some minor extraneous peaks were observed only in stool samples from patients with chronic hepatic porphyria, e. g., porphyria cutanea tarda.
Simultaneous separation of the four coproporphyrin isomers I-IV was performed by isocratic ion-pair HPLC on a 5 μιη LiChrosorb RP-18 column (Merck) using tetrabutylammonium phosphate as the ion-pairing reagent (5) . The isomer proportions were calculated from peak area ratios.
Scanning of fluorescence spectra
Fluorescence spectra of the individual coproporphyrin isomers were recorded with a programmable HPLC fluorescence detector (model F-1080, Merck), using the stop-flow technique. A slit width of 10 nm was used. Emission spectra were scanned from 450 to 800 nm after excitation at 396 nm (Soret band). Excitation spectra were recorded from 250 to 600 nm with the emission wavelength fixed at 624 nm.
Results and Discussion
Sample preparation method
The presence of coproporphyrinogens in human faeces was first demonstrated by Fischer & Orth (9) in a case with congenital erythropoietic porphyria, and later by Watson et al. (10) in non-porphyric patients. Pudek et al. (11), however, were unable to detect porphyrinogens in a series of stool samples. We started our sample preparation method with an oxidation step in order to avoid any non-enzymatic isomerization of the acidrl bile ροφΓΐ>τίηο$6η5 (12, 13) . Once porphyrins are formed, they are absolutely stable to further isomerization.
A combined extraction procedure including hydrochloric acid and methanol/iso-propanol as organic modifier was applied to remove chlorophyll derivatives present in faeces (14) .
The naturally occurring coproporphyrin free carboxylic acids were isolated using a recently developed reversedphase ion-pair TLC method, published elsewhere (15) . Direct TLC separation of faecal porphyrin free carboxylic acids is faster and has an increased overall recovery Fluorescence spectra of coproporphyrin isomers I -IV Positive identification of the four coproporphyrin isomers I-IV was achieved by on-line recording of their emission and excitation fluorescence spectra in faeces from a patient with hereditary coproporphyria. All four coproporphyrins exhibited the same emission spectra with a strong band at 624 nm and a broad shoulder of low intensity at ca. 670 nm ( fig. 2a ). In addition, identical excitation spectra with a characteristic structure were observed ( fig. 2b ). The latter showed an intense Soret band at 396 nm and smaller bands at 500, 536 and 570 nm, respectively. These spectra are comparable to those of the corresponding absorption spectra. In previous studies, we confirmed the presence of all four coproporphyrin isomers in stool samples of healthy subjects by on-line diode-array recording of their absorption spectra (16) .
The high sensitivity of fluorescence spectroscopy enabled us to scan complete spectra of as little as 1 ng coproporphyrin on the column.
Methodological criteria
The recovery rates were determined by adding various amounts of the individual coproporphyrin isomers to four uniform stool samples containing 67.0% isomer I, 30.5% isomer HI, 0.7% isomer II and 1.8% isomer IV. The mean analytical recovery was 101 ± 1% (χ ± S. D.) for isomer I, 98 ± 1% for isomer III, 90 ± 8% for isomer II and 94 ± 4% for isomer IV.
The precision of the method was checked by assaying seven times a normal stool sample with an isomeric composition similar to that given above. The resulting coefficients of variation for isomer I, isomer III, isomer II and isomer IV were 0.8%, 1.7%, 5.7% and 3.9%, respectively. Obviously, the precision depends on the relative abundance of the corresponding isomer.
Composition of faecal coproporphyrin isomers I-IV in control subjects and in various porphyrias
The isomeric composition of faecal coproporphyrins j_IV was determined in 20 control subjects and 60 patients suffering from the common types of hereditary porphyria (tab. 2). The ratios of coproporphyrin isomers III to I and the combined percentages of the atypical isomers II and IV in individual stool samples are presented in figs. 3 and 4, respectively.
Copropoiphyrin I was the predominant isomer in faeces of healthy controls (tab. 2, fig. 3 ), which agrees with earlier studies (17) (18) (19) . High percentages of isomer I and decreased proportions of isomers II, III and IV were observed in erythropoietic porphyrias like congenital erythropoietic porphyria and protqporphyria (tab. 2, figs. 3 and 4).
A significantly higher ratio of coproporphyrin isomers III to I was found in acute hepatic porphyria, e. g. acute intermittent porphyria and porphobilinogen synthase parison. » deficiency porphyria, in contrast to chronic hepatic porphyria like po hyria cutanea tarda (p < 0.005, tab. 3). In addition, the combined percentages of the atypical isomers II and IV were significantly higher in acute than in chronic hepatic porphyria (p < 0.03, tab. 3). In our study, the isomer III to I ratios of patients with acute intermittent porphyria exceeded slightly those reported by Minder (20) .
Hereditary coproporphyria and variegate porphyria exhibited markedly elevated isomer III to I ratios ( fig. 3) , besides increased proportions of the atypical isomers II and IV (fig. 4) . The predominance of faecal coproporphyrin III in hereditary coproporphyria and variegate porphyria has been reported by others (20) (21) (22) (23) .
Atypical coproporphyrins II and IV were detected in each stool sample from both control subjects and porphyria patients; the relative content varied between 0.5 and 10.0% of total coproporphyrins. Surprisingly, the percentages of isomers II and IV were closely correlated with that of isomer III (r = 0.98), whereas a strong inverse correlation was observed in the case of isomer I (r = -0.97).
Pathobiogenesis of faecal coproporphyrin isomers I -IV
Formation and excretion of faecal coproporphyrin isomers I-IV in porphyria patients are complex processes, which may be influenced by several factors, e. g. nature of the specific enzyme defect, excretion mode of the individual isomers by the liver cell, relative content of porphyrinogens, and possible contamination by porphyrins of bacterial (24) or dietary (25) origin.
Normally, an isomer ratio of 2 : 1 for coproporphyrins III and I is found in liver cells (17) . The excretion rate of coproporphyrin I in bile is nearly twofold higher than that of isomer III (26) . Approximately 90% of total coproporphyrin I is excreted in faeces due to the superior elimination capacity of bile (18) , whereas isomer III is predominantly found in urine.
Porphyrinogens were detected by Logan et al. (27) in human bile in substantial amounts, varying between 2 and 32% of total porphyrins. Watson et al. (10) showed that coproporphyrinogens in bile and faeces account for 2 to 50% of total coproporphyrins.
Coproporphyrinogens can be isomerized in a post-hepatic, non-enzymatic and pH-dependent process to form both the physiological isomers I and III, and the atypical isomers II and IV (12, 28) . The isomerization is thermodynamically controlled, so that isomers II and IV are produced in an obligatory ratio of 1 :2 (12), as confirmed in our study (tab. 2). The mechanism of this reaction includes opening of the porphyrinogen ring, formation of a spirocyclic intermediate, and subsequent rearrangement of one pyrrolic moiety (29, 30 The elevated excretion of coproporphyrin I in faeces and urine of patients with congenital erythropoietic porphyria is due to the almost complete deficiency of uroporphyrinogen ΙΠ cosynthase activity. Presence of coproporphyrinogen I in faeces of such patients (9) gives rise to the post-hepatic formation of the atypical isomers II and IV via non-enzymatic isomerization.
The increased proportion of coproporphyrin I in faeces of patients with protoporphyria corresponds to that in urine (4) and originates from hepatic involvement due to protoporphyrin accumulation (31) . The content of biliary porphyrinogens in protoporphyria patients is very low (27) , so that the formation of the atypical isomers II and IV is sharply reduced.
The faecal and urinary excretion of coproporphyrin ΙΠ in patients with either acute intermittent porphyria or the extremely rare porphobilinogen synthase deficiency porphyria (32) is significantly higher as compared with that in porphyria cutanea tarda, resulting from a compensatory counterregulatory enhancement of porphyrinogen biosynthesis in the former conditions (32) . The percentages of the atypical isomers II and IV are significantly higher in faeces of patients with acute hepatic porphyria as compared with those in chronic hepatic porphyria, probably due to a higher excretion of biliary and/or faecal porphyrinogens in acute hepatic porphyria.
In variegate poiphyria, protoporpnyrinogen and protoporphyrin are accumulated because of a deficiency of protoporphyrinogen oxidase lism of the intermediate copΓOpoφhyrinogen III, resulting in an increased excretion of coproporphyrin III in faeces (tab. 2, fig. 3 ) and urine (4) . In addition, the relatively high content of porphyrinogens in the bile of such patients (ca. 26% of total porphyrins) (27) results in enhanced formation of the atypical isomers II and IV in faeces (tab. 2, fig. 4 ).
The highest proportions of coproporphyrins II, III and IV were found in faeces of patients suffering from hereditary coproporphyria, where deficient coproporphyrinogen oxidase activity is responsible for the largely raised excretion of isomer III in faeces (tab. 2, fig. 3 ) and urine (4) . The markedly increased formation of the atypical isomers II and IV arises from non-enzymatic isomerization of the abundant coproporphyrinogen III.
Excretion of faecal porphyrins other than coproporphyrin
Polar porphyrins, e. g., uroporphyrin, hepta-and hexacarboxyporphyrin, are normally found in faeces only in trace amounts. Heptacarboxyporphyrin and especially isocoproporphyrin are characteristic porphyrins in faeces of patients with chronic hepatic porphyria and its cutaneous manifestation phase, porphyria cutanea tarda (1). A minimal increase of coproporphyrins in porphyria cutanea tarda is common in patients with excessive porphyrijauria, whereas faecal protoporphyrin is slightly elevated in cases with heavy alcohol consumption (33) .
Increased faecal excretion of pentacarboxyporphyrin can be found in hereditary coproporphyria and variegate porphyria together with raised coproporphyrin III levels, resulting in a ratio of about 1 : 10 (34).
The lipophilic protoporphyrin is exclusively eliminated via bile and faeces, serving as the essential diagnostic finding in variegate porphyria (1). An additional rise in tricarboxypoφhyrin and coproporphyrin III may occur simultaneously (35) .
In harderoporphyria, the recessive variant of hereditary coproporphyria, a typical increase of the metabolite harderoporphyrin (tricarboxyporphyrin) is observed (1, 36).
Protoporphyria is characterized by greatly raised erythrocyte protoporphyrin concentration, causing a concomitant protpporphyrinaeniia and increased biliary elimination of ρΓοΐοροφΙι^Ίΐη. Hepatic involvement due to deposition of crystalline, hepatotoxic ρΓοίοροφΙτχιίη occurs in about 25% of cases (31) . Protoporphynn-mduced liver complications result in progressive cholestatic cirrhosis with a βΐ^φ^ diminished hepatobiliary excretion capacity for ρπ>ίοροφ1ψπη. Consequently, the erythrocyte ρΓοίοροφΙ^Γΐη levels increase even further, which ultimately may require liver transplantation (37) .
Diagnostic relevance of faecal coproporphyrin isomers I -IV
Greatly increased proportions of faecal ^ρΓοροφΙ^Γΐη I together with decreased proportions of isomers II, III and IV are typical findings in the biochemical diagnosis of congenital erythropoietic porphyna.
In protoporphyna and poφhyria cutanea tarda, patterns of faecal οορπ)ροφ1^Γίη8 I-IV are similar and cannot be used to distinguish these two conditions. Although differences in coproporphynn isomer ratios in poiphyria cutanea tarda and acute intermittent porphyna as well as in ροφΙιοΜΙπ^βη synthase deficiency poφhyria are statistically significant (tab. 3), their diagnostic relevance is compromised by the overlap of ranges (figs. 3 and 4) .
The isomer ratios of οορΓοροφ!ν/πη8 III to I display an extraordinary increase in faeces from patients with variegate ροφίτ^^ and especially in hereditary copropoφhyria as compared with the other ροφ1^ΓΪ35 ( fig.  3 ). Due to the strong positive correlation between the physiological isomer III and the atypical isomers II and IV, the latter serve as additional diagnostic markers ( fig.  4 ). For example, the percentage of οορΓοροφΙ^πη IV exceeds that of isomer I in faeces of patients with hereditary οορΓοροφΙ^η^ ( fig. Ib) . Variegate poφhyria and hereditary ^ρΓοροφ1^Γί3 can be clearly distinguished by comparing the respective excretion of faecal coproporphynns and ρΓΟίοροφΙτ/ηη (tab. 1) (1).
Analysis of faecal coproporphyrin isomers I -IV in a family with hereditary coproporphyria
The ratio of faecal ^ρΓοροφΙ^ιίη isomers III to I was used successfully for screening adult patients at risk of hereditary coproperphyna in a large family study by Blake et al. (22) , and by Sieg & Doss (38) .
In our study, we analysed the total faecal rins and the relative proportions of the isomers I-IV in 6 members of a family with hereditary οορπ>ροφ!ΐ)α( tab. 4). The index patient of this family (daughter 1) presented with severe abdominal attacks. She excreted large amounts of faecal οορΓοροφΙτ^τίηβ with greatly raised proportions of the physiological isomer III besides the atypical isomers II and IV (tab. 4). Her father, her sister and her brother 2 excreted elevated amounts of faecal οορΓοροφΙ^Γΐη5, too, and nearly identical isomer ratios. Here, the combined determination of total faecal and the isomeric composition of copro- ) gene, although they synthase deficiency porphyria as compared with porwere so far clinically asymptomatic. On the other hand, phyria cutanea tarda, the diagnostic value of these fmdthe mother and the brother 1 of the index patient showed ings is compromised by an overlap of ranges. normal excretion of total faecal coproporphyrins and a normal composition of the four coproporphyrin isomers, ™ e m°f ly increased P r°P°rtions of faec^ coproporwhich makes the presence of a deficient coproporphy- proportions of isomer I, are found in variegate porphyria and especially in hereditary coproporphyria, providing a Thus, analysis of total faecal coproporphyrins, combined good diagnostic marker for these conditions. with the proportions of their isomers I-IV, provided a simple identification of affected members in this family
In family studies > automatic gene carriers for herediwith hereditary copropoiphyria, and it confirmed previtary ^Proporphyria with normal faecal excretion of ous findings with isomers I and III (22, 38) . Analysis of ^Ρ^ΡΟΦ^Π^ can be detected by the inversion of urinary coproporphyrin isomers in the same subjects . Thus, determination of the proportions of faecal coproonc usion porphyrin isomers I-IV offers valuable information for An improved sample preparation method enabled the rethe dkgposis and differential diagnosis of porphyrias. 
